Zevra Therapeutics embarks on diagnosis push as Miplyffa launch gains steam
Niemann-Pick disease type C therapy Miplyffa became commercially available in late November and by the year's end, a total of 109 prescription enrollment forms had been submitted. The company estimates there are around 900 patients with the disease in the U.S.
Niemann-Pick disease type C therapy Miplyffa became commercially available in late November and by the year's end, a total of 109 prescription enrollment forms had been submitted. The company estimates there are around 900 patients with the disease in the U.S.
